海创药业-U
(688302)
| 流通市值：30.21亿 | | | 总市值：30.21亿 |
| 流通股本：9901.56万 | | | 总股本：9901.56万 |
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 每股收益(元) | -0.57 | -0.30 | -1.39 | -1.00 | -0.62 | -0.32 | -2.01 | -1.56 |
| 每股净资产(元) | 10.17 | 10.44 | 10.74 | 11.12 | 11.49 | 11.75 | 12.04 | 12.44 |
| 每股资本公积金(元) | 26.18 | 26.18 | 26.17 | 26.17 | 26.16 | 26.12 | 26.09 | 26.02 |
| 每股未分配利润(元) | -17.00 | -16.73 | -16.43 | -16.05 | -15.67 | -15.37 | -15.05 | -14.59 |
| 每股经营性现金流(元) | -0.47 | -0.11 | -1.10 | -0.81 | -0.48 | -0.36 | -1.89 | -1.41 |
| 净资产收益率(%) | -5.43 | -2.85 | -12.17 | -8.65 | -5.31 | -2.73 | -15.59 | -11.86 |
| 营业总收入(元) | 5497.06万 | 2602.55万 | 2046.99万 | 2335.18万 | 1316.71万 | - | 36.68万 | 10.97万 |
营业总收入同比增长(%) | 317.48 | - | 5480.11 | 21180.28 | 11899.08 | - | - | - | | 归属净利润(元) | -5621.81万 | -2988.20万 | -13725.26万 | -9914.72万 | -6185.32万 | -3210.18万 | -19949.57万 | -15407.14万 |
| 归属净利润同比增长(%) | 9.11 | 6.91 | 31.20 | 35.65 | 38.40 | 32.01 | 32.18 | 35.28 |
| 扣非净利润(元) | -6757.44万 | -3553.66万 | -16787.17万 | -11990.47万 | -7300.56万 | -3746.07万 | -21750.99万 | -16734.21万 |
|
| 扣非净利润同比增长(%) | 7.44 | 5.14 | 22.82 | 28.35 | 33.63 | 28.94 | 33.08 | 36.06 |
| 毛利率(%) | 97.34 | 99.82 | 98.62 | 99.57 | 99.52 | - | 8.43 | 12.04 |
| 净利率(%) | -102.27 | -114.82 | -670.51 | -424.58 | -469.75 | - | -54382.77 | -140403.81 |
| 资产负债率(%) | 20.86 | 19.61 | 18.80 | 19.24 | 18.32 | 11.16 | 12.44 | 12.33 |
| 存货周转率(次) | 0.16 | 0.01 | 0.20 | 0.27 | 0.12 | - | 66.30 | 1.13 |